SEC Form 4 · accession 0000899243-18-025549
ARVINAS, INC. · ARVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Crew
Officer — See Remarks
Period of report
Sep 26, 2018
Accepted (ET)
Sep 28, 2018 · 8:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001655759
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $16.00 | Sep 26, 2018 | A | 15,860 | A | — | Sep 25, 2028 | Common Stock | 15,860 | 15,860 | D |
| Stock Option (right to buy)F2 | $16.00 | Sep 26, 2018 | A | 10,390 | A | — | Sep 25, 2028 | Common Stock | 10,390 | 10,390 | D |
| Stock Option (right to buy)F3 | $16.00 | Sep 26, 2018 | A | 5,340 | A | — | Sep 25, 2028 | Common Stock | 5,340 | 5,340 | D |
| Stock Option (right to buy)F4 | $16.00 | Sep 26, 2018 | A | 2,600 | A | — | Sep 25, 2028 | Common Stock | 2,600 | 2,600 | D |
| Stock Option (right to buy)F5 | $16.00 | Sep 26, 2018 | A | 20,440 | A | — | Sep 25, 2028 | Common Stock | 20,440 | 20,440 | D |
| Stock Option (right to buy)F6 | $16.00 | Sep 26, 2018 | A | 34,550 | A | — | Sep 25, 2028 | Common Stock | 34,550 | 34,550 | D |
| Stock Option (right to buy)F7 | $16.00 | Sep 26, 2018 | A | 5,110 | A | — | Sep 25, 2028 | Common Stock | 5,110 | 5,110 | I |
Explanation of responses
- F1This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant.
- F2This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017, with the remainder of the shares vesting in equal monthly installments following January 1, 2017 through January 1, 2020.
- F3This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of December 13, 2017, with the remainder of the shares vesting in equal monthly installments following December 13, 2017 through December 13, 2020.
- F4This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022.
- F5This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022.
- F6This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022.
- F7This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on April 9, 2019, with the remainder of the shares vesting in equal monthly installments following April 9, 2019 through April 9, 2022.
Remarks
Senior Vice President, Chemistry